Molecular Mechanisms of Turmeric in Inflammatory Pathways

Abstract

Turmeric (Curcuma longa) is one of the most extensively studied botanicals in modern pharmacology, with curcumin and related curcuminoids interacting with a wide set of inflammatory signalling nodes. The published mechanistic literature is large but fragmented, with studies covering individual pathways in isolation and little consolidation of how those individual mechanisms add up to the clinical anti-inflammatory profile observed in trials. We carried out a structured mechanistic review of 92 primary studies published between 2005 and 2021 describing molecular actions of curcumin and curcumin-analogue preparations in inflammatory pathways. Included studies were grouped under five mechanistic frames: M1 (NF-kB pathway modulation), M2 (COX/LOX eicosanoid pathway), M3 (MAPK signalling), M4 (Nrf2 and antioxidant-response axis), and M5 (cytokine-network integrated anti-inflammatory effect). Each frame was scored with the Turmeric Anti-Inflammatory Index (TAI), a weighted composite across mechanistic evidence strength, in vivo translation, clinical corroboration, target specificity, and translational/therapeutic yield. Cytokine-network effects (M5) and NF-kB modulation (M1) emerged as the best-supported frames with TAI values of 0.894 and 0.866 respectively, both replicated across in vitro, in vivo and clinical studies. Nrf2-axis activation (M4) scored well for mechanistic quality but has thinner clinical corroboration. The consolidated picture is that curcumin's clinical anti-inflammatory profile is genuinely multi-target, with NF-kB inhibition and the integrated cytokine-network downshift as the two most clinically-anchored mechanisms.